EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice

Narongsuk Munkong iD, Surasawadee Somnuk, Nattanida Jantarach iD, Kingkarnonk Ruxsanawet, Piyawan Nuntaboon, Vaiphot Kanjoo, Bhornprom Yoysungnoen iD

Nutrients · 2023-01-03 · 15 (1) · 246

DOI: 10.3390/nu15010246 ↗

At a glance

Journal article in Nutrients, published online on 2023-01-03. Written by Narongsuk Munkong and 6 co-authors. Institution: Department of Pathology, School of Medicine, University of Phayao, Phayao 56000, Thailand. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Oryza, Dyslipidemias. Cited 24 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: Thailand Science Research and Innovation Fund, University of Phayao, Thailand, Research Group in Exercise and Aging-Associated Diseases, Faculty of Medicine, Thammasat University, Thailand.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Red rice bran extract (RRBE) is rich in phytonutrients and has been shown to have anti-diabetic, anti-inflammatory, and antioxidant properties. However, its anti-hepatic steatosis and anti-dyslipidemic properties have not been thoroughly investigated. This study examined the aforementioned properties of RRBE, the underlying mechanism by which it alleviated non-alcoholic fatty liver disease in high-fat diet (HFD)-fed mice, and its major bioactive constituents. The mice were divided into four groups based on their diet: (1) low-fat diet (LFD), (2) LFD with high-dose RRBE (1 g/kg/day), (3) HFD, and (4) HFD with three different doses of RRBE (0.25, 0.5, and 1 g/kg/day). The administration of RRBE, especially at medium and high doses, significantly mitigated HFD-induced hepatosteatosis and concomitantly improved the serum lipid profile. Further, RRBE modified the level of expression of lipid metabolism-related genes (adipose triglyceride lipase (ATGL), cluster of differentiation 36 (CD36), lipoprotein lipase (LPL), liver X receptor alpha (LXRα), sterol regulatory element-binding protein-1c (SREBP-1c), SREBP-2, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), and carnitine palmitoyltransferase 1A (CPT1A)) in hepatic or adipose tissues and improved the expression of hepatic high-density lipoprotein cholesterol (HDL-C) cmetabolism-related genes (hepatic lipase (HL) and apolipoprotein A-ǀ (ApoA-ǀ)). RRBE also attenuated markers of liver injury, inflammation, and oxidative stress, accompanied by a modulated expression of inflammatory (nuclear factor-kappa B (NF-κB) and inducible nitric oxide synthase (iNOS)), pro-oxidant (p47phox), and apoptotic (B-cell lymphoma protein 2 (Bcl-2)-associated X and Bcl-2) genes in the liver. High-performance liquid chromatography analyses indicated the presence of protocatechuic acid, γ-oryzanol, vitamin E, and coenzyme Q10 in RRBE. Our data indicate that RRBE alleviates HFD-induced hepatosteatosis, dyslipidemia, and their pathologic complications in part by regulating the expression of key genes involved in lipid metabolism, inflammation, oxidative stress, and apoptosis.

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseaseOryzaDyslipidemiasMiceAnimalsDiet, High-FatLiverLipid MetabolismInflammationAnti-Inflammatory AgentsMice, Inbred C57BL

Author keywords

dyslipidemiahigh-fat dietnon-alcoholic fatty liver diseaseobesityred rice bran

Substances

Anti-Inflammatory Agents

Authors and institutions

  • Department of Pathology, School of Medicine, University of Phayao, Phayao 56000, Thailand.
  • Division of Nutrition for Health and Sport, Department of Sport and Health Sciences, Faculty of Sport Science, Kasetsart University, Nakhon Pathom 73140, Thailand.
  • Applied Thai Traditional Medicine Program, School of Public Health, University of Phayao, Phayao 56000, Thailand.
  • Division of Biochemistry, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
  • Agriculture Program, School of Agriculture and Natural Resources, University of Phayao, Phayao 56000, Thailand.
  • Division of Physiology, Department of Preclinical Science, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand.

ORCID profiles: Narongsuk Munkong, Nattanida Jantarach, Bhornprom Yoysungnoen

Funding

  • Thailand Science Research and Innovation Fund
  • University of Phayao, Thailand
  • Research Group in Exercise and Aging-Associated Diseases, Faculty of Medicine, Thammasat University, Thailand

Cite

APA

Munkong, N., Somnuk, S., Jantarach, N., Ruxsanawet, K., Nuntaboon, P., Kanjoo, V., & Yoysungnoen, B. (2023). Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice. Nutrients, 15(1), 246. https://doi.org/10.3390/nu15010246

Vancouver

Munkong N, Somnuk S, Jantarach N, Ruxsanawet K, Nuntaboon P, Kanjoo V, et al. Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice. Nutrients. 2023;15(1):246. doi:10.3390/nu15010246

BibTeX
@article{Munkong2023,
  author = {Munkong, Narongsuk and Somnuk, Surasawadee and Jantarach, Nattanida and Ruxsanawet, Kingkarnonk and Nuntaboon, Piyawan and Kanjoo, Vaiphot and Yoysungnoen, Bhornprom},
  title = {Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {246},
  doi = {10.3390/nu15010246}
}
Start for free →